Authors


Elevate-Derm Conference

Latest:

RAPIDS 2025 Conference Recap: A Thrilling Journey Through Immuno-Dermatology

RAPIDS 2025 captivated with expert insights on immuno-dermatology, featuring engaging sessions and lively panels.


Neha Kinariwalla

Latest:

Looking at the scalp and nails during a skin exam is key

A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.


Dawn Eichenfield, MD, PhD

Latest:

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.





Melissa Kanchanapoomi Levin, MD, FAAD

Latest:

Unmasking Botulinum Toxin Myths

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.


David Cotter, MD, PhD

Latest:

AI Trends in Dermatology: Talking With David Cotter, MD, PhD at DERM 2025

Dermatology has the opportunity of directing and leading AI use in the field, according to David Cotter, MD, PhD.


Amy Spizuoco, DO, FAOCD

Latest:

A Deep Dive into Alopecia Treatments, Novel STIs, and the Future of Dermatology

Amy Spizuoco, DO, FAOCD, shares groundbreaking insights on alopecia treatments and emerging STIs at this year's Elevate-Derm Summer Conference, enhancing patient care.


Christine Blank

Latest:

Drug Price Hikes Already Found in 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.


Marcella R. Aquino, MD, FACAAI

Latest:

Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash Dx

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.


Matthew Reedy, MD

Latest:

Administrative Burden of Prescribing Biologics

Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.



Hershel Dobkin, MD, FAAD

Latest:

A Million Ways to Get Behind in a Dermatology Clinic

Hershel Dobkin, MD, FAAD, shares his experiences and the surprising reasons behind clinic delays, from patient needs to unexpected moments.


Cheri Frey, MD, FAAD

Latest:

Melanocyte Preservation and Future Directions for Laser Technology

Cheri Frey, MD, discusses how emerging laser technologies are advancing melanocyte-sparing treatments while developing more precise targeting capabilities and enhanced safety features for diverse skin types.


Maureen Offiah, MD

Latest:

A Clinician’s Perspective of RAD 2025: Part 2

At RAD 2025, Maureen Offiah, MD, reflected on the sessions she felt were the most impactful as an attendee.


Steve Feldman, MD, PhD

Latest:

Ensure Patient Adherence in Pediatric Atopic Dermatitis Cases

Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.


Brittany Scurto, PA-C

Latest:

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.



Sana Suhail

Latest:

Pediatric Melanoma in Review: Providing Considerations for Dermatologists

Pediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.


Kamran H. Imam, MD

Latest:

Award Recipient to Focus on Atopic Dermatitis in Native Americans

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.



Logan Lutton

Latest:

Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA

If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.


Matthew Gavidia

Latest:

Study: Lifestyle Behaviors Linked With Psoriasis Development

Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.


Cameron Clements, NP-C

Latest:

How to Best Support Women With Menopausal Acne

Menopausal acne is rising yet underexplored; treatment must address hormonal shifts, skin sensitivity, and patient emotional well-being.


Laura Ferris, MD, PhD

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Michael Cameron, MD, FAAD

Latest:

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.


Adel Haque, MD

Latest:

Managing Atopic Dermatitis Postpartum and While Breastfeeding

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.


Shawn Kwatra, MD, FAAD

Latest:

Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis

Shawn Kwatra, MD, FAAD, reviews his late-breaking data presentation at AAD on the first original studies of a topical cream for prurigo nodularis.


Jeff Bendix

Latest:

Burnout, Frustration Levels Continue to Grow Among Physicians

Doctors cite more support staff, reduced patient panels among solutions.

© 2025 MJH Life Sciences

All rights reserved.